Delivery Order SPE2DB22D9304-SPE2DB25FSTB3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,553.15 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, awarded on June 2, 2025, with completion targeted for June 24, 2025, represents a direct pharmaceutical supply requirement for federal healthcare operations. The award carries no set-aside designation, demonstrating...
- The Defense Logistics Agency awarded a delivery order valued at $7,536.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 15, 2025, and was awarded on September 23, 2025. No set-aside designation was utilized for this award, indicating the vendor competed on an unrestricted...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,855.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
- The Defense Logistics Agency awarded a delivery order valued at $15,063.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, issued on September 10, 2025, is scheduled for completion by October 1, 2025. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a delivery order valued at $7,531.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, awarded on September 12, 2025, with an ultimate completion date of October 3, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract involves no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, awarded on September 19, 2025, with an ultimate completion date of October 10, 2025, represents a direct pharmaceutical supply fulfillment to support Department of Defense medical facilities. The award carries no...
- The U.S. Defense Logistics Agency awarded a delivery order contract worth $5,711.28 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract, contract 4600082013, held by DMS Pharmaceutical Group with the Defense Logistics Agency under the SPE2DB program. The IDV, valued up to $4,999,999 through 2025,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,488.11 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product, with a period of performance through December 8, 2023. This order is placed under a larger indefinite delivery contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $37,659.45 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 MG/20 ML vials. The contract, awarded on September 9, 2025, with an ultimate completion date of September 30, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,510.63 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. The delivery order, which will be completed by August 11, 2025, is for 266 mg/20 mL vials of EXPAREL, a local anesthetic medication commonly used in surgical and pain management applications. This award was issued without a set-aside...
- SPE2DB22D9304Indefinite Delivery Contract
- SPE2DB22D9304-SPE2DB25FSTB3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,057.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. This firm fixed-price delivery order, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, represents a continuation of the agency's pharmaceutical supply chain operations without set-aside designation. The award leverages DMS Pharmaceutical Group's established capabilities in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to federal healthcare facilities. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The underlying IDC, operating under the SPE2DB program, enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's consistent success in securing federal pharmaceutical contracts without set-aside designations, combined with its woman-owned small business status, has established the company as a crucial supplier within the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 9/9/25 |